Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite following intravenous administration in cattle

Tropical Animal Health and Production
K UneyMehmet Maden

Abstract

This study investigated the pharmacokinetics of pentoxifylline (PTX) and its 5-hydroxyhexyl metabolite (M-I) after single-dose intravenous (IV) administration (10 mg/kg) of PTX in six healthy cattle. The safety of PTX was evaluated by clinical observation and biochemical analysis. Plasma concentrations of PTX and M-I were simultaneously determined by reverse-phase high performance liquid chromatography. Pharmacokinetic parameters were calculated using non-compartmental methods. Salivation and discomfort were observed for 2 h following the drug administration. Serum direct bilirubin, total bilirubin, and phosphorus levels at 24 h following the drug administration were significantly different from the control values (0 h) (P < 0.05). Pharmacokinetic variables of PTX were characterized by a short terminal elimination half-life (1.05 ± 0.19 h), a large volume of distribution (6.30 ± 1.76 L/kg), and high total body clearance (5.31 ± 1.27 L/h/kg). The mean ratio between the area under the concentration-time curves of M-I and PTX was 1.34. These results indicate that single-dose administration of PTX at 10 mg/kg IV in cattle resulted in therapeutic concentrations similar to those observed in humans and horse. However, further studies ...Continue Reading

References

Mar 1, 1990·Clinical Pharmacology and Therapeutics·A RamesP Jaillon
Jan 1, 1986·Journal of Pharmaceutical Sciences·R V SmithH B Lassman
Feb 1, 1986·Journal of Pharmaceutical Sciences·D R LukeC Hoholick
Jan 1, 1985·Clinical Pharmacology and Therapeutics·B BeermannA McDonald
Apr 1, 1994·Journal of the American Academy of Dermatology·C P Samlaska, E A Winfield
Sep 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D J HonessN M Bleehen
Mar 1, 1993·Journal of Veterinary Pharmacology and Therapeutics·M V CrismanM H Irby
Jul 1, 1996·Research in Veterinary Science·M F LandoniP Lees
Jun 13, 2000·American Journal of Veterinary Research·R MarsellaS M Roberts
Jul 19, 2002·Chirality·Marie NicklassonPeter Höglund
Feb 13, 2003·Journal of Clinical Monitoring and Computing·R RegenthalR Preiss
Dec 9, 2003·Research in Veterinary Science·B SzotákováL Skálová
Jun 15, 2004·Biochemical Pharmacology·Theresa C PetersonFrank J Gonzalez
Dec 14, 2004·Biochemical Pharmacology·Zandong YangJerry L Nadler
Dec 14, 2005·Journal of Veterinary Pharmacology and Therapeutics·S De BoeverS Croubels
Jan 27, 2007·Pharmacotherapy·Kim G AdcockShirley M Hogan
Mar 6, 2010·Handbook of Experimental Pharmacology·Pierre-Louis ToutainAlain Bousquet-Mélou
Aug 31, 2010·Paediatric Drugs·Emma HarrisSanjay K Patole
Jun 12, 2012·Inflammation & Allergy Drug Targets·Seray Külcü ÇakmakÜlker Gül
Nov 1, 2013·Drug Metabolism Reviews·Petra Malátková, Vladimír Wsól
Jul 14, 2017·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Kishan S ItaliyaAnupama Mittal

❮ Previous
Next ❯

Citations

Sep 14, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Min ChenBaojian Wu

❮ Previous
Next ❯

Software Mentioned

HP PC - controlled LC solution
SPSS
WinNonlin

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.